A patient with Renal cell carcinoma is on treatment with Erythropoetin. Erythropoetin use may be associated with all of the following, except:
Decreased reticulocytes
Increased hemtocrit
Increased hemoglobin
Eliminates need for transfusion
Treatment with erythropoietin stimulates erythrocyte production and results in an increase in reticulocyte count. Reticulocyte count is not decreased. So 'Decreased reticulocytes is the single best answer of choice'. Ref: Harrison's Principles of Internal Medicine, 16th Edition, Page 667